Incyte | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
Acadia Pharmaceuticals USD 40.21M 12.43M 2025-06
Agios Pharmaceuticals USD -112020000 22.73M 2025-06
Alnylam Pharmaceuticals USD -35358000 6.24M 2025-06
Amgen USD 1.57B 405M 2025-06
Biogen USD 744M 432.8M 2025-06
BioMarin Pharmaceutical USD 297.87M 59.78M 2025-06
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Eli Lilly USD 6.78B 3.32B 2025-06
Exelixis USD 230.42M 24.72M 2025-06
Gilead Sciences USD 2.43B 780M 2025-06
Incyte USD 558.01M 323.82M 2025-06
Ionis Pharmaceuticals USD 124M 271M 2025-06
MacroGenics USD -14477000 70.79M 2024-12
Merck USD 6.77B 864M 2025-06
Moderna USD -818000000 146M 2025-06
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Novartis USD 4.53B 124M 2025-06
Novartis USD 4.66B 269M 2024-12
Pfizer USD 3.04B 259M 2025-06
PTC Therapeutics USD -71052000 1B 2025-06
Regeneron Pharmaceuticals USD 1.52B 613.7M 2025-06
Sarepta Therapeutics USD 153.64M 537.16M 2025-06
Ultragenyx Pharmaceutical USD -114004000 35.77M 2025-06
Vertex Pharmaceuticals USD 1.28B 552.6M 2025-06


Incyte L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.